Oncogenic KRAS effector USP13 promotes metastasis in non-small cell lung cancer through deubiquitinating β-catenin

Yanguan Guo1, Jiaxin Tian2, Yongjian Guo2

  • 1School of Biopharmacy, China Pharmaceutical University, Nanjing 211198, P.R. China; Department of General Surgery and Department of Thoracic Surgery, The First Affiliated Hospital of Jinan University, Guangzhou 510632, P.R. China.

Cell Reports
|December 3, 2023
PubMed

Insights

Researchers identified USP13 as a key driver of metastasis in KRAS-mutant non-small cell lung cancer (NSCLC). Targeting USP13 with 2-methoxyestradiol offers a potential new treatment strategy for advanced NSCLC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • KRAS mutations are common in non-small cell lung cancer (NSCLC), but treatments for many KRAS-mutant NSCLCs remain limited.
  • Developing targeted therapies requires understanding KRAS effectors that drive poor prognosis.

Purpose of the Study:

  • To identify novel therapeutic targets for KRAS-mutant NSCLC.
  • To investigate the role of KRAS-driven effectors in NSCLC metastasis.

Main Methods:

  • Investigated the role of deubiquitinase USP13 in KRAS-driven NSCLC.
  • Examined the mechanism of USP13 in regulating β-catenin and TCF4 interaction.
  • Screened a natural compound library for USP13 inhibitors.

Main Results:

  • KRAS signaling upregulates USP13 expression via RREB1.
  • Elevated USP13 promotes NSCLC metastasis and is linked to poor patient prognosis.
  • USP13 deubiquitinates β-catenin, enhancing its binding to TCF4.
  • 2-methoxyestradiol effectively inhibits USP13 and suppresses NSCLC metastasis in vitro and in vivo.

Conclusions:

  • USP13 is a KRAS effector that promotes metastasis in NSCLC.
  • USP13 is a potential therapeutic target for KRAS-mutant metastatic NSCLC.
  • 2-methoxyestradiol shows promise as a treatment for KRAS-mutant NSCLC.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
2.3K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.7K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K